In this podcast episode, the pressing issue of shortages in generic sterile injectables is examined. It highlights how these vital medications are at risk due to low profit margins, complex manufacturing processes, and strict regulations that prevent price flexibility. Industry experts, including Ned McCoy, engage in thought-provoking discussions that emphasize the urgent need for a shift in government policies and hospital purchasing methods to build a more robust supply chain. The episode ultimately advocates for collective efforts to prioritize the reliability of these essential medications over simple cost reductions, posing an important question: would patients be willing to pay more for guaranteed access to their medications?
